These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9123923)

  • 1. A safety study of Albumex 5, a human albumin solution produced by ion exchange chromatography.
    Wolf M; Kronenberg H; Dodds A; Miach P; Isbister J; Levidiotis M; Dear K
    Vox Sang; 1996; 70(4):198-202. PubMed ID: 9123923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatographic removal and heat inactivation of hepatitis A virus during manufacture of human albumin.
    Adcock WL; MacGregor A; Davies JR; Hattarki M; Anderson DA; Goss NH
    Biotechnol Appl Biochem; 1998 Aug; 28(1):85-94. PubMed ID: 9693093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatographic removal and heat inactivation of hepatitis B virus during the manufacture of human albumin.
    Adcock WL; MacGregor A; Davies JR; Hattarki M; Anderson DA; Goss NH
    Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():169-78. PubMed ID: 9756468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience of using human albumin solution 4.5% in 1195 therapeutic plasma exchange procedures.
    Pusey C; Dash C; Garrett M; Gascoigne E; Gesinde M; Gillanders K; Wallington T
    Transfus Med; 2010 Aug; 20(4):244-9. PubMed ID: 20230532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human serum albumin induced hypotension in the postoperative phase of cardiac surgery.
    Howard G; Downward G; Bowie D
    Anaesth Intensive Care; 2001 Dec; 29(6):591-4. PubMed ID: 11771600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uneventful plasma exchange with albumin replacement in a patient with a previous anaphylactoid reaction to albumin.
    Edelman BB; Straughn MA; Getz P; Schwartz E
    Transfusion; 1985; 25(5):435-6. PubMed ID: 4049490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hypotensive reactions is increased when using partial saline replacement for therapeutic plasma exchange.
    Irani MS; Toushan M; Zhang L; Simpson PM; Karafin MS
    J Clin Apher; 2019 Oct; 34(5):524-527. PubMed ID: 30888726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion-removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins.
    Thyer J; Unal A; Thomas P; Eaton B; Bhashyam R; Ortenburg J; Uren E; Middleton D; Selleck P; Maher D
    Vox Sang; 2006 Nov; 91(4):292-300. PubMed ID: 17105604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Side effects of therapeutic plasma exchange. A controlled prospective study].
    Mercatello A; Laville M; Leizorovicz A
    Presse Med; 1989 Feb; 18(7):325-9. PubMed ID: 2522625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionation of outdated freeze-dried plasma: a comparative study of cold- and heat-ethanol fractionation procedures.
    Schneider W; Wolter D; Shapiro M; McCarty L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):109-16. PubMed ID: 88384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical improvements in heat-ethanol isolation of serum albumin.
    Schneider W; Wolter D; McCarty LJ
    Blut; 1976 Oct; 33(4):275-80. PubMed ID: 990486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of human albumin--serious adverse events reported worldwide in 1998-2000.
    Vincent JL; Wilkes MM; Navickis RJ
    Br J Anaesth; 2003 Nov; 91(5):625-30. PubMed ID: 14570782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mep HyperCel for polishing of human serum albumin.
    McCann KB; Vucica Y; Wu J; Bertolini J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():241-8. PubMed ID: 25195026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validation of the virus inactivation capacity of a procedure of human plasma albumin purification by chromatography].
    Stoltz JF; Geschier C; Rivat C; Sertillanges P; Grandgeorges M; Liautaud J; Regnault V; Dumont L
    Ann Pharm Fr; 1993; 51(2):78-93. PubMed ID: 8250488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and plasma derivatives in therapeutic plasmapheresis.
    McLeod BC
    Transfusion; 2012 May; 52 Suppl 1():38S-44S. PubMed ID: 22578370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange in the intensive care unit: Technical aspects and complications.
    Lemaire A; Parquet N; Galicier L; Boutboul D; Bertinchamp R; Malphettes M; Dumas G; Mariotte E; Peraldi MN; Souppart V; Schlemmer B; Azoulay E; Canet E
    J Clin Apher; 2017 Dec; 32(6):405-412. PubMed ID: 28146331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein and colloid osmotic pressure changes with albumin and/or saline replacement during plasma exchange.
    Lasky LC; Finnerty EP; Genis L; Polesky HF
    Transfusion; 1984; 24(3):256-9. PubMed ID: 6729943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.
    O'Brien KL; Price TH; Howell C; Delaney M
    J Clin Apher; 2013 Dec; 28(6):416-21. PubMed ID: 23857424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of manufacturing improvements on clinical safety of albumin: Australian pharmacovigilance data for 1988-2005.
    Che Y; Wilson FJ; Bertolini J; Schiff P; Maher DW
    Crit Care Resusc; 2006 Dec; 8(4):334-8. PubMed ID: 17227271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperchloremic metabolic acidosis following plasma exchange during myasthenia gravis crisis.
    Ritzenthaler T; Grousson S; Dailler F
    J Clin Apher; 2016 Oct; 31(5):479-80. PubMed ID: 26390995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.